Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Navigating Seasonal Challenges in Life Sciences Quality Assurance

Jul 24, 2025

Understanding Seasonal Variability in Life Sciences QA

The life sciences industry is inherently dynamic, with seasonal variations influencing various aspects of quality assurance (QA). These fluctuations can stem from environmental factors, regulatory changes, or supply chain disruptions. Successfully navigating these seasonal challenges is crucial for maintaining high standards of quality and compliance.

Seasonal changes can impact raw material availability and quality, which in turn affects production processes. For example, certain biological materials may be more abundant in specific seasons, leading to a surplus in supply but potential variability in quality. Understanding these patterns allows QA teams to anticipate potential issues and implement proactive strategies.

life sciences production

Adapting to Regulatory Changes

Regulatory landscapes are continually evolving, with updates often occurring on a seasonal basis. Staying informed about these changes is essential for QA teams to ensure compliance and avoid potential penalties. It's important to establish a robust monitoring system to track regulatory updates and incorporate them into the company's quality standards promptly.

Implementing a periodic review process can help ensure that all regulatory requirements are met. This strategic approach allows teams to adjust their processes and documentation to align with new regulations, thereby minimizing compliance risks.

Managing Supply Chain Disruptions

Supply chain disruptions are a common challenge in the life sciences industry, often exacerbated by seasonal factors such as adverse weather conditions or fluctuating demand. These disruptions can lead to delays in production and distribution, ultimately impacting product quality.

supply chain management

To mitigate these risks, it's essential to develop a flexible supply chain strategy that includes multiple suppliers and contingency plans. This approach helps ensure the continuous availability of high-quality materials and reduces dependency on a single source.

Ensuring Equipment Maintenance

Seasonal changes can also affect equipment performance, with temperature fluctuations leading to potential malfunctions or inefficiencies. Regular maintenance is critical to ensuring that all equipment operates at optimal levels throughout the year.

A comprehensive maintenance schedule should be established, taking into account seasonal variations that could impact equipment performance. This proactive approach minimizes downtime and supports consistent product quality.

equipment maintenance

Enhancing Workforce Preparedness

The effectiveness of a QA strategy often depends on the competence and readiness of the workforce. Seasonal changes may bring challenges such as staff shortages due to holidays or increased demand for training on new processes or regulations.

Investing in continuous training programs and flexible workforce management strategies can enhance the team's ability to adapt to seasonal challenges. Encouraging open communication and collaboration within the team further strengthens the QA process.

Leveraging Technology for Better Outcomes

Technology plays a pivotal role in overcoming seasonal challenges in life sciences quality assurance. Advanced analytics and monitoring tools can provide real-time insights into process performance, helping teams identify potential issues before they escalate.

Implementing digital solutions such as automated reporting systems and predictive maintenance tools can significantly enhance operational efficiency and ensure consistent quality standards are upheld throughout the year.

quality assurance technology

In conclusion, navigating seasonal challenges in life sciences quality assurance requires a multifaceted approach that combines proactive planning, regulatory awareness, supply chain resilience, and technological advancements. By understanding and addressing these challenges, businesses can maintain high-quality standards and ensure compliance year-round.